Drug Type Synthetic peptide |
Synonyms HYFT 71216c, HYFT71216c |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Discovery | United States | 01 Mar 2025 | |
Metabolic Diseases | Discovery | Belgium | 01 Mar 2025 |